ES503283A0 - Un procedimiento para la obtencion de una preparacion esta- ble de un agente antibacteriano de beta-lactama liofilizado - Google Patents

Un procedimiento para la obtencion de una preparacion esta- ble de un agente antibacteriano de beta-lactama liofilizado

Info

Publication number
ES503283A0
ES503283A0 ES503283A ES503283A ES503283A0 ES 503283 A0 ES503283 A0 ES 503283A0 ES 503283 A ES503283 A ES 503283A ES 503283 A ES503283 A ES 503283A ES 503283 A0 ES503283 A0 ES 503283A0
Authority
ES
Spain
Prior art keywords
lactama
procedure
obtaining
antibacterial agent
stable preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES503283A
Other languages
English (en)
Other versions
ES8203887A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of ES503283A0 publication Critical patent/ES503283A0/es
Publication of ES8203887A1 publication Critical patent/ES8203887A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ES503283A 1980-06-23 1981-06-22 Un procedimiento para la obtencion de una preparacion esta- ble de un agente antibacteriano de beta-lactama liofilizado Expired ES8203887A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8578980A JPS5711909A (en) 1980-06-23 1980-06-23 Stable freeze-dried preparation of beta-lactam

Publications (2)

Publication Number Publication Date
ES503283A0 true ES503283A0 (es) 1982-04-01
ES8203887A1 ES8203887A1 (es) 1982-04-01

Family

ID=13868648

Family Applications (1)

Application Number Title Priority Date Filing Date
ES503283A Expired ES8203887A1 (es) 1980-06-23 1981-06-22 Un procedimiento para la obtencion de una preparacion esta- ble de un agente antibacteriano de beta-lactama liofilizado

Country Status (31)

Country Link
US (1) US4418058A (es)
JP (1) JPS5711909A (es)
KR (1) KR840000693B1 (es)
AR (1) AR230007A1 (es)
AT (1) AT380790B (es)
AU (1) AU541627B2 (es)
BE (1) BE889351A (es)
BG (1) BG37991A3 (es)
CA (1) CA1164801A (es)
CH (1) CH648210A5 (es)
CS (1) CS221835B2 (es)
DD (1) DD159879A5 (es)
DE (1) DE3124592A1 (es)
DK (1) DK158443C (es)
ES (1) ES8203887A1 (es)
FI (1) FI75490C (es)
FR (1) FR2484835A1 (es)
GB (1) GB2078737B (es)
GR (1) GR75646B (es)
HU (1) HU183494B (es)
IE (1) IE51331B1 (es)
IL (1) IL63136A (es)
IT (1) IT1144812B (es)
NL (1) NL191777C (es)
NO (1) NO156036C (es)
NZ (1) NZ197414A (es)
PT (1) PT73239B (es)
RO (1) RO82720B (es)
SE (1) SE460702B (es)
YU (1) YU44416B (es)
ZA (1) ZA814203B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS597193A (ja) * 1982-07-02 1984-01-14 Shionogi & Co Ltd マロニルメチル基の異性化方法
JPS6045514A (ja) * 1983-08-22 1985-03-12 Shionogi & Co Ltd 安定な抗菌性凍結乾燥製剤
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
US4891391A (en) * 1985-01-03 1990-01-02 Morton Thiokol, Inc. Compositions containing antimicrobial agents in combination with stabilizers
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
DE3801179A1 (de) * 1988-01-18 1989-07-27 Hoechst Ag Stabilisierung von cephalosporinderivaten durch trocknung mit einem stabilisator sowie stabile zubereitungsformen mit cephalosporinderivaten
CA2415922A1 (en) * 2000-07-13 2002-01-24 Daiichi Pharmaceutical Co., Ltd. Pharmaceutical compositions containing dds compound
US7378408B2 (en) * 2001-11-30 2008-05-27 Pfizer Inc. Methods of treatment and formulations of cephalosporin
US9872906B2 (en) 2013-03-15 2018-01-23 Merck Sharp & Dohme Corp. Ceftolozane antibiotic compositions
NZ700372A (en) 2013-03-15 2016-01-29 Merck Sharp & Dohme Ceftolozane antibiotic compositions
US20140274997A1 (en) 2013-03-15 2014-09-18 Cubist Pharmaceuticals, Inc. Cephalosporin pharmaceutical compositions
EP3043797B1 (en) 2013-09-09 2020-04-08 Merck Sharp & Dohme Corp. Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
US8906898B1 (en) 2013-09-27 2014-12-09 Calixa Therapeutics, Inc. Solid forms of ceftolozane

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS532931B2 (es) * 1973-12-05 1978-02-01
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions
US3993753A (en) * 1974-08-26 1976-11-23 American Home Products Corporation Anhydrous ampicillin stabilization and resultant compositions
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
JPS5151511A (en) * 1974-10-25 1976-05-07 Tooru Tatsuhara Aminosanseizai no anteikaho
US4180571A (en) * 1976-03-25 1979-12-25 Shionogi & Co., Ltd. Arylmalonamido-1-oxadethiacephalosporins
JPS532931A (en) * 1976-06-30 1978-01-12 Saraya Kk Toilet bowl cleaning method
FI773796A (fi) * 1976-12-17 1978-06-18 Leitzinger Oy Foerfarande foer framstaellning av antibiotisk blandning
JPS53104722A (en) * 1977-02-19 1978-09-12 Tsumura Juntendo Kk Production of powder for making herb medicine liquid agent
CA1127450A (en) * 1978-08-26 1982-07-13 Gordon L. Mcglennon Load multiplying mechanisms
US4259485A (en) * 1979-04-24 1981-03-31 Eli Lilly And Company Crystallization process

Also Published As

Publication number Publication date
SE8103904L (sv) 1981-12-24
DK158443B (da) 1990-05-21
RO82720B (ro) 1984-07-30
IT8167863A0 (it) 1981-06-22
NL8102943A (nl) 1982-01-18
FR2484835A1 (fr) 1981-12-24
NL191777C (nl) 1996-08-02
DK158443C (da) 1990-10-08
DK274981A (da) 1981-12-24
DE3124592A1 (de) 1982-02-11
AU541627B2 (en) 1985-01-17
IE51331B1 (en) 1986-12-10
GR75646B (es) 1984-08-02
HU183494B (en) 1984-05-28
FI75490C (fi) 1988-07-11
CS221835B2 (en) 1983-04-29
ATA278881A (de) 1985-12-15
NO812090L (no) 1981-12-28
GB2078737B (en) 1984-03-14
YU44416B (en) 1990-08-31
ES8203887A1 (es) 1982-04-01
SE460702B (sv) 1989-11-13
NZ197414A (en) 1984-10-19
NO156036C (no) 1987-07-15
JPS6364405B2 (es) 1988-12-12
IE811347L (en) 1981-12-23
BG37991A3 (en) 1985-09-16
JPS5711909A (en) 1982-01-21
NO156036B (no) 1987-04-06
FI811948L (fi) 1981-12-24
AT380790B (de) 1986-07-10
CH648210A5 (de) 1985-03-15
IL63136A (en) 1984-07-31
FI75490B (fi) 1988-03-31
ZA814203B (en) 1982-09-29
IT1144812B (it) 1986-10-29
KR830005848A (ko) 1983-09-14
IL63136A0 (en) 1981-09-13
PT73239A (en) 1981-07-01
RO82720A (ro) 1984-05-23
DD159879A5 (de) 1983-04-13
AR230007A1 (es) 1984-02-29
CA1164801A (en) 1984-04-03
KR840000693B1 (ko) 1984-05-21
NL191777B (nl) 1996-04-01
US4418058A (en) 1983-11-29
BE889351A (fr) 1981-10-16
DE3124592C2 (es) 1990-12-20
AU7209781A (en) 1983-01-06
PT73239B (en) 1982-07-22
GB2078737A (en) 1982-01-13
FR2484835B1 (es) 1983-07-01
YU157381A (en) 1984-10-31

Similar Documents

Publication Publication Date Title
ES498055A0 (es) Un procedimiento para la preparacion de una piridilanilina
ES504905A0 (es) Un procedimiento para la preparacion de una nueva formulacion de bacampicilina.
ES502980A0 (es) Un procedimiento para la preparacion de una macrolida
ES490018A0 (es) Un procedimiento para la preparacion de una nueva composi- cion de copolieterester.
ES499924A0 (es) Procedimiento para la preparacion de un agente de valoracion
ES494692A0 (es) Un procedimiento para la preparacion de una composicion de monoesteres y diesteres de sacarosa tensoactiva.
ES487319A0 (es) Procedimiento para la preparacion de una composicion de cau-cho vulcanizada
ES503188A0 (es) Un procedimiento para la preparacion de una 1-benzoil-urea 3-sustituida
ES506992A0 (es) Un procedimiento para la preparacion de una macroliada.
ES502546A0 (es) Procedimiento para la preparacion de nuevas n-ariloxazolidi-nonas-2
ES525544A0 (es) Un procedimiento para la preparacion de una macrolida
ES499609A0 (es) Un procedimiento para la preparacion de una 3-yodometil-ce- falosporina
ES503283A0 (es) Un procedimiento para la obtencion de una preparacion esta- ble de un agente antibacteriano de beta-lactama liofilizado
ES484916A0 (es) Un procedimiento para la preparacion de una composicion ter-moplastica.
AR228468A1 (es) Procedimiento para la preparacion de nuevas imidazolil-fenilamidinas
ES504741A0 (es) Un procedimiento para la preparacion de una composicion esporicida de dialdehido-diol.
ES530081A0 (es) Un procedimiento para la preparacion de una macrolida
MX7528E (es) Procedimiento para la preparacion de una vacuna sintetica
ES503682A0 (es) Un procedimiento para la preparacion de una isoxazolilimida-zolidinona
AR227563A1 (es) Procedimiento para la preparacion de antibioticos de macrolida
ES493596A0 (es) Un procedimiento para la preparacion de una composicion ten soactiva.
ES501464A0 (es) Procedimiento para la preparacion de nuevas fenilureas
MX159494A (es) Procedimiento para la preparacion de una masa silico-calcarea
ES486022A0 (es) Un procedimiento para la preparacion de antibioticos de ce- falosporina
ES505786A0 (es) Un procedimiento para la preparacion de una quinolona

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020213